Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus

INTRODUCTION: We compared the economic impacts of linezolid and vancomycin for the treatment of hospitalized patients with methicillin-resistant Staphylococcus aureus (MRSA)–confirmed nosocomial pneumonia. METHODS: We used a 4-week decision tree model incorporating published data and expert opinion...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Crit Care
Autors principals: Patel, Dipen A, Shorr, Andrew F, Chastre, Jean, Niederman, Michael, Simor, Andrew, Stephens, Jennifer M, Charbonneau, Claudie, Gao, Xin, Nathwani, Dilip
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4220084/
https://ncbi.nlm.nih.gov/pubmed/25053453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/cc13996
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars